All Insights

Patient having temperature taken.

MoD spin-out Presymptom Health raises £1.5m

To develop AI-driven sepsis and infection tests. UK start-up Presymptom Health has raised £1.5m in follow-on seed and grant funding that will help accelerate time to market of its AI-driven sepsis and infection tests...

ExactTrak

UKI2S Portfolio Company ExactTrak secures £1 million investment

ExactTrak, a leading player in UK cybersecurity who recently secured a UK Government contract, has successfully raised £1 million to fix a gap in cybersecurity...

HONUWORX

HonuWorx goes subsea, offering game-changing, emission-reducing, economy-boosting tech

HonuWorx uses ingenious tech to deliver zero-emission underwater operations...

image of presympton health

UKI2S portfolio company, Presymptom Health, joins government pilot

To get AI-driven infection test into the NHS faster helping to tackle Anti-Microbial Resistance.

Productive Machines Technologies

Improve efficiency, productivity and sustainability with Productive Machines

NetZero by 2030. Responsible investment. Environmental action. Social inclusion. Impact-first – that’s the mission. The…

Douglas Hansen-Luke

Dinner is Served: Investment Predictions for 2024

By Douglas Hansen-Luke, Executive Chairman and Founder of Future Planet Capital (FPC) - Fund Manager of UKI2S

Oxford Space System

Oxford Space Systems’ £3M Funding Round

Supported by UK Ministry Of Defence contributed through UKI2S. Oxford Space Systems announces the successful completion of a £3 million equity investment...

HALO X-ray Technologies

HALO’s novel X-ray diffraction technology will strengthen global security

Proving its X-ray diffraction technology (XRD) has the potential to enhance security, improve passenger facilitation, increase throughput, and reduce airport operational costs.

An image of the Grand Prismatic Spring (licensed from photographer Werner van Steen), representing the origin of our sulfur-utilizing mitochondrial ancestors

MitoRx Therapeutics Announces Close of Seed Extension Financing Round

To Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases

Bioengineering

Ingredients that don’t cost the earth.

Building sustainability with engineering biology and AI...

End of content

No more pages to load